Enhanced Vessel Flow Control Systems and Methods

The present invention relates to improved systems and methods for controlling vessel flow rate and/or pressure, enhancing treatment outcomes for afflicted vessels and/or tissues. The inventive concept leverages real-time monitoring of vessel health and functional status to dynamically adjust the occlusion factor of flow control devices, ensuring personalized and optimized vessel treatment.

The original patent disclosed systems and methods for controlling vessel flow rate and/or pressure. However, these systems had limitations in terms of adjusting to changing vessel conditions and providing personalized treatment. The present invention addresses these limitations by integrating real-time monitoring and machine learning algorithms to optimize vessel flow control, resulting in more effective and efficient treatment.

The inventive concept comprises a flow control device with a dynamically adjustable occlusion factor, which is adjusted based on real-time data from an integrated sensor or external monitoring systems. The sensor data is used to optimize vessel treatment by predicting optimal flow control parameters. The system can also include a machine learning algorithm to personalize vessel flow control based on individual patient data. The method of enhancing vessel flow control involves receiving real-time data on vessel health and functional status and adjusting the flow control device accordingly.

The new claims introduce the concept of real-time monitoring and dynamic adjustment of the occlusion factor, which is not present in the original patent. This innovation enables personalized and optimized vessel treatment, addressing the limitations of the original systems and methods.

Alternative embodiments of the inventive concept could include using different types of sensors or monitoring systems, integrating the system with other medical devices, or using different machine learning algorithms. Variations could also include applying the inventive concept to different types of vessels or tissues.

The inventive concept has significant commercial potential in the medical device industry, particularly in the areas of cardiovascular and neurovascular treatment. The system could be marketed as a standalone device or integrated into existing medical systems, offering a competitive advantage in terms of personalized and optimized vessel treatment.